Market Value426,439,000
Total Holdings49
File Date2018-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ACAD / ACADIA Pharmaceuticals Inc. Call
DERM / Journey Medical Corporation
ICPT / Intercept Pharmaceuticals Inc Call
ZGNX / Zogenix Inc Put
DRNA / Dicerna Pharmaceuticals Inc
NVRO / Nevro Corp.
XLRN / Acceleron Pharma Inc
LJPC / La Jolla Pharmaceutical Co.
ZBH / Zimmer Biomet Holdings, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
ABYLY / Ablynx NV
OBSV / ObsEva SA.
ENTL / Entellus Medical, Inc.
TMO / Thermo Fisher Scientific Inc.
ONCE / Spark Therapeutics, Inc.
0PP / Portola Pharmaceuticals Inc
FXB / Invesco CurrencyShares British Pound Sterling Trust
RYTM / Rhythm Pharmaceuticals, Inc.
SIOX / Sio Gene Therapies Inc.
PTCT / PTC Therapeutics, Inc. Call
AERI / Aerie Pharmaceuticals Inc
ESPR / Esperion Therapeutics, Inc.
US00C4U1L353 / Mylan N.V.
MRK / Merck & Co., Inc.
018490100 / Allergan plc
018490100 / Allergan plc Call
ZGNX / Zogenix Inc
NSTG / NanoString Technologies, Inc.
EXEL / Exelixis, Inc.
US3723091043 / GenMark Diagnostics, Inc
NUVA / Nuvasive Inc
/ Immunomedics, Inc. Call
JUNO / Juno Therapeutics, Inc.
US64052L1061 / Neos Therapeutics, Inc.
0HBB / Aimmune Therapeutics Inc Call
CRSP / CRISPR Therapeutics AG
/ Immunomedics, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) Put
ARAV / Aravive, Inc.
/ Array BioPharma, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
BSX / Boston Scientific Corporation
PDCO / Patterson Companies, Inc.
IRIX / IRIDEX Corporation
CELG / Celgene Corp. Call
CPRX / Catalyst Pharmaceuticals, Inc.
451731103 / Ignyta, Inc.
RARX / Ra Pharmaceuticals, Inc.
NLTX / Neoleukin Therapeutics, Inc.
ICPT / Intercept Pharmaceuticals Inc
0HBB / Aimmune Therapeutics Inc
BMY / Bristol-Myers Squibb Company
US0153511094 / Alexion Pharmaceuticals, Inc.
KDMN / Kadmon Holdings Inc
HZNP / Horizon Therapeutics Plc
GBT / Global Blood Therapeutics Inc.
CLVS / Clovis Oncology Inc
BMY / Bristol-Myers Squibb Company Call
BCRX / BioCryst Pharmaceuticals, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
BHVN / Biohaven Ltd.
NBRV / Nabriva Therapeutics Plc
FOLD / Amicus Therapeutics, Inc.
IRTC / iRhythm Technologies, Inc.
EDIT / Editas Medicine, Inc.
AVXS / AveXis, Inc.
AVXS / AveXis, Inc. Put
NTLA / Intellia Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
QTNT / Quotient Ltd
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
GWP / GW Pharmaceuticals plc
SRPT / Sarepta Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc. Put
SAGE / Sage Therapeutics, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
INSM / Insmed Incorporated
NBIX / Neurocrine Biosciences, Inc.
VRAY / ViewRay Inc.
PBYI / Puma Biotechnology, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
MRTX / Mirati Therapeutics, Inc.
PTCT / PTC Therapeutics, Inc.
INCY / Incyte Corporation
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
INSM / Insmed Incorporated Call
RCKT / Rocket Pharmaceuticals, Inc.
BPMC / Blueprint Medicines Corporation